Milan Paleja to Head Novartis India's Pharmaceuticals Business
Novartis India has appointed Mr. Milan Paleja as its new President. He will succeed Mr. Jawed Zia, who left the drug maker in March for rival Abbott India. Mr. Paleja, previously President and head of pharmaceuticals for Novartis Indonesia, will also head Novartis India’s pharmaceutical business, according to a company release. “While in Indonesia, he pioneered innovative access models, turned around the business and laid the foundation for future growth,” stated the release. He is a graduate from Bombay University and holds a Cost Accountants degree from the Institute of Cost Accountants of India.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
Best Price Glow70 High Purity 99% Custom Peptide Scientifically Formulated for Skin Radiance and Tissue Repair
$5E+1/UNIT FOB
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Three Major Indian Chemical Investments Target China's PC Exports
-
Pharmaconex
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Beyond Compliance: Building Quality Maturity
Recommend Reading
-
![Shell Plans to Sell U.S. Chemical Assets for Up to $8 Billion, with ExxonMobil and LyondellBasell Joining the Bidding]()
Shell Plans to Sell U.S. Chemical Assets for Up to $8 Billion, with ExxonMobil and LyondellBasell Joining the Bidding
-
![Titanium Dioxide: Stuck Between Weak Upside and Limited Downside]()
Titanium Dioxide: Stuck Between Weak Upside and Limited Downside
-
![Azelis Acquires 100% Stake in Specialty Chemical Distributor Distona]()
Azelis Acquires 100% Stake in Specialty Chemical Distributor Distona
-
![Intercos Plans Acquisition of US Companies to Expand Beyond Cosmetics]()
Intercos Plans Acquisition of US Companies to Expand Beyond Cosmetics
-
![BASF and Encina Bet on Circular Chemical Feedstocks]()
BASF and Encina Bet on Circular Chemical Feedstocks
-
![Phosphate Market Prices Slightly Decline (9.22-9.26)]()
Phosphate Market Prices Slightly Decline (9.22-9.26)
-
![Aniline Market Sees Slight Increase This Week (9.22–9.26)]()
Aniline Market Sees Slight Increase This Week (9.22–9.26)
-
![September Adipic Acid Market Fluctuates and Declines]()
September Adipic Acid Market Fluctuates and Declines
-
![Geopolitical Risks Ease & Demand Weakens—Crude Oil Slides to a Phase-Low Level]()
Geopolitical Risks Ease & Demand Weakens—Crude Oil Slides to a Phase-Low Level
-
![September Adipic Acid Market Experiences Fluctuating Decline]()
September Adipic Acid Market Experiences Fluctuating Decline
